Skip to content.

Metabolic Syndrome Institute

You are here: Home » Highlights


Highlights

Up one level
Nonfasting triglyceride levels are independently associated with incident cardiovascular events
Fasting triglyceride levels show little independent association
Does microvascular dysfunction impair insulin-mediated glucose uptake by muscle?
The microcirculation may be a target for prevention and treatment of the metabolic syndrome.
Silent myocardial ischaemia
Independent association with the metabolic syndrome in patients with type 2 diabetes.
Omniheart Trial
Effects of the three different diets on blood pressure and serum lipids
Metabolic Syndrome and Acute Myocardial Infarction
Prevalence of the metabolic syndrome in acute MI and impact of hyperglycaemia on hospital outcomes
Interheart Study
Prevention of cardiovascular disease: a worldwide core of nine risk factors for myocardial infarction
Endothelial dysfunction
Metabolic syndrome correlates with endothelial dysfunction of coronary microvasculature in patients with normal coronary arteries.
Metabolic Syndrome and target organ damage
Frequently present in early stages of hypertension
An emerging risk factor for cognitive decline
Elderly subjects with the Metabolic Syndrome are at higher risk of cognitive decline over 4 years.
The ARIC study
Increased cardiovascular morbidity and mortality in individuals with the Metabolic Syndrome.
The Metabolic Syndrome amplifies hypertension-related cardiac and renal changes
Target organ damage may explain the enhanced cardiovascular risk associated with the Metabolic Syndrome.
UN Resolution caps momentous year for diabetes world
The United Nations General Assembly has passed a landmark Resolution recognizing the global threat of the diabetes epidemic. Read the Press Release issued by the International Diabetes Federation to stress the importance of the Resolution, which is "a first for non-infectious diseases."
International medical news:
WHICH DRUG THERAPY FOR THE METABOLIC SYNDROME ?
NHANES III : Correlation between microalbuminuria and the metabolic syndrome
The metabolic syndrome is associated with a cluster of disorders such as abdominal obesity, insulin-resistance, hypertension, and dyslipidaemia. This study is the first to assess the correlation between microalbuminuria as defined by WHO and the metabolic syndrome defined by NCEP ATP III criteria) in a large US population.
Ongoing Trials
Metabolic Syndrome Institute Landmark Studies
Guidelines
Metabolic Syndrome Institute Guidelines
Cardiovascular risks calculators
Metabolic Syndrome Institute Cardiovascular risks calculators
How to measure your waistline ?
Metabolic Syndrome Institute Measure your waistline
MSI Meeting
Newsletter

Metabolic Syndrome Institute Newsletter
MSI special session at WCC 2008
Web Conference
Metabolic Syndrome Institute Web Conferences
MSI 2007 Awards winners
Awards
Metabolic Syndrome Institute AWARDS
 

This site conforms to the following standards: